Germantown's Precigen raises $75M to advance treatments for rare diseases
The clinical-stage company is developing gene and cell therapies for cancers, autoimmune disorders and infectious diseases.
Source: bizjournals.com Health Care:Physician Practices headlines - Category: American Health Authors: Sara Gilgore Source Type: news
More News: American Health | Autoimmune Disease | Cancer | Cancer & Oncology | Genetics | Health Management | Infectious Diseases | Rare Diseases